A Pilot First In Man Study of EXCEL-Ⅱto Treat the Patients With de Novo Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

June 4, 2019

Conditions
IschemiaCoronary Artery Disease
Interventions
DEVICE

EXCEL-Ⅱ

A PILOT First-In-Man Study to evaluate safety and efficacy of the EXCEL-Ⅱ with New Cobalt ChRomium Alloys Sirolimus Eluting BioDegradable Polymer Stent In the Treatment of Patients with de novo Coronary Artery Lesions

Trial Locations (1)

110015

Shenyang Northern Hospital, Shenyang

Sponsors
All Listed Sponsors
lead

JW Medical Systems Ltd

INDUSTRY